Saba Capital Management L.P. reduced its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 25.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 189,003 shares of the company’s stock after selling 63,835 shares during the quarter. Saba Capital Management […]